Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell S Cairo

Showing results (191-200 of 268) with videos related to

Pageof 27
Sort By:
American Journal of Hematology|January 1, 2003
Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experienceMitchell S Cairo, Richard Sposto, Margo Hoover-Regan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2011
Umbilical cord blood transplantation for children with thalassemia and sickle cell diseaseAnnalisa Ruggeri, Mary Eapen, Andromachi Scaravadou, et al.
Molecular Therapy. Oncology|June 27, 2024
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimenPrakash Satwani, Monica Bhatia, James H Garvin, et al.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Blood|July 1, 2022
KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trialMichael A Pulsipher, Kwang W Ahn, Nancy J Bunin, et al.
British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08Mark A Lones, Nyla A Heerema, Michelle M Le Beau, et al.
Bone Marrow Transplantation|June 15, 2018
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemiaJessica Hochberg, Stacey Zahler, Mark B Geyer, et al.
Bone Marrow Transplantation|February 3, 2022
Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplantSusan K Parsons, Angie Mae Rodday, Ruth Ann Weidner, et al.
Pageof 27

Showing results (191-200 of 268) with videos related to

Sort By:
Pageof 27
American Journal of Hematology|January 1, 2003
Childhood and adolescent large-cell lymphoma (LCL): a review of the Children's Cancer Group experienceMitchell S Cairo, Richard Sposto, Margo Hoover-Regan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2011
Umbilical cord blood transplantation for children with thalassemia and sickle cell diseaseAnnalisa Ruggeri, Mary Eapen, Andromachi Scaravadou, et al.
Molecular Therapy. Oncology|June 27, 2024
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 15, 2011
A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimenPrakash Satwani, Monica Bhatia, James H Garvin, et al.
Molecular Therapy. Oncology|February 9, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 <i>in vitro</i> and <i>in vivo</i> in NB xenograftsYaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Blood|July 1, 2022
KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trialMichael A Pulsipher, Kwang W Ahn, Nancy J Bunin, et al.
British Journal of Haematology|June 6, 2003
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell dosesOlle Ringdén, A John Barrett, Mei-Jie Zhang, et al.
Cancer Genetics and Cytogenetics|December 19, 2006
Chromosome abnormalities in advanced stage lymphoblastic lymphoma of children and adolescents: a report from CCG-E08Mark A Lones, Nyla A Heerema, Michelle M Le Beau, et al.
Bone Marrow Transplantation|June 15, 2018
The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemiaJessica Hochberg, Stacey Zahler, Mark B Geyer, et al.
Bone Marrow Transplantation|February 3, 2022
Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplantSusan K Parsons, Angie Mae Rodday, Ruth Ann Weidner, et al.
Pageof 27